Live Breaking News & Updates on Viking Therapeutics Daily

Stay updated with breaking news from Viking therapeutics daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Viking Therapeutics, Inc. (NASDAQ:VKTX) Receives $112.38 Average Target Price from Brokerages

Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) have been assigned an average rating of “Buy” from the nine brokerages that are currently covering the stock, MarketBeat Ratings reports. Eight investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average […] ....

Raymond James , Stifel Nicolaus , William Blair , Greg Zante , Marianna Mancini , Castleark Management , Maxim Group , Therapeutics Inc , Cetera Advisors , Artal Group , Therapeutics Company Profile , Securities Exchange Commission , Comerica Bank , Viking Therapeutics , Get Free Report , Marketbeat Ratings , Exchange Commission , Investment Advisers , Get Free , Viking Therapeutics Daily ,

Viking Therapeutics, Inc. (NASDAQ:VKTX) Receives $112.38 Average Price Target from Analysts

Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) have received an average rating of “Buy” from the nine ratings firms that are covering the firm, Marketbeat reports. Eight equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 1-year […] ....

Greg Zante , Marianna Mancini , Maxim Group , Therapeutics Inc , Lifesteps Financial Inc , Massmutual Trust Co , Therapeutics Company Profile , Global Retirement Partners , Lindbrook Capital , Jefferies Financial Group , Viking Therapeutics , Get Free Report , Truist Financial , Steps Financial , Wealth Management , Retirement Partners , Get Free , Viking Therapeutics Daily ,

Viking Therapeutics (NASDAQ:VKTX) Upgraded at StockNews.com

StockNews.com upgraded shares of Viking Therapeutics (NASDAQ:VKTX – Free Report) to a sell rating in a research report report published on Friday. Other research analysts have also issued reports about the stock. William Blair reissued an outperform rating on shares of Viking Therapeutics in a report on Friday, February 23rd. HC Wainwright restated a buy […] ....

United States , Stifel Nicolaus , Marianna Mancini , Greg Zante , William Blair , Vanguard Group Inc , American Century Companies Inc , Hood River Capital Management , Securities Exchange Commission , Avoro Capital Advisors , Therapeutics Company Profile , Therapeutics Inc , Viking Therapeutics , Free Report , Moderate Buy , Therapeutics Stock Down , Get Free Report , Exchange Commission , Capital Advisors , Century Companies , Viking Therapeutics Daily ,

Viking Therapeutics' (VKTX) Buy Rating Reaffirmed at Truist Financial

Truist Financial reissued their buy rating on shares of Viking Therapeutics (NASDAQ:VKTX – Free Report) in a report published on Thursday morning, Benzinga reports. They currently have a $120.00 price objective on the biotechnology company’s stock. A number of other analysts have also recently weighed in on VKTX. BTIG Research increased their price objective on […] ....

Greg Zante , Raymond James , Marianna Mancini , Jefferies Financial Group , International Assets Investment Management , Therapeutics Inc , Securities Exchange Commission , Vanguard Group Inc , Rafferty Asset Management , Therapeutics Company Profile , Raymond James Associates , Truist Financial , Viking Therapeutics , Free Report , Moderate Buy , Therapeutics Stock Down , Get Free Report , Exchange Commission , Asset Management , Assets Investment Management , Aigen Investment Management , Viking Therapeutics Daily ,

Viking Therapeutics (NASDAQ:VKTX) Earns "Buy" Rating from Truist Financial

Truist Financial reaffirmed their buy rating on shares of Viking Therapeutics (NASDAQ:VKTX – Free Report) in a research report sent to investors on Thursday morning, Benzinga reports. The firm currently has a $120.00 target price on the biotechnology company’s stock. A number of other equities analysts have also weighed in on the stock. StockNews.com upgraded […] ....

Marianna Mancini , Raymond James , William Blair , Greg Zante , Securities Exchange Commission , Therapeutics Inc , Wetzel Investment Advisors Inc , Massmutual Trust Co , Lindbrook Capital , Jefferies Financial Group , Lifesteps Financial Inc , Truist Financial , Viking Therapeutics , Free Report , Moderate Buy , Therapeutics Stock Down , Get Free Report , Exchange Commission , Investment Advisors , Steps Financial , Spire Wealth Management , Viking Therapeutics Daily ,